Top 5 Wellness VC (Venture Capital) Funds in Taiwan in January 2026
A list of 5 VC (Venture Capital) funds that invest in Wellness startups based in Taiwan. We rank investors based on the number of investments they made in Wellness companies from Taiwan. We update this investor list every month.Top 5 Wellness VC (Venture Capital) Funds in Taiwan in January 2026
| Investor | Wellness Taiwan investments |
|---|---|
| Guangzhou Yuexiu Industrial Investment Fund | 1 |
| Zero2IPO Ventures | 1 |
| Sino Biopharmaceutical | 1 |
| Panacea Venture | 1 |
| Suzhou Industrial Park Nankai Venture Capital | 1 |
Guangzhou Yuexiu Industrial Investment Fund is a corporate investment arm of Yue Xiu Enterprises (Holdings) Limited.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Series B, Series C, Series A
- China, United States, Taiwan
Portfolio highlights
- REDPINE — REDPINE is a medical healthcare instrument providing industry.
- HongQing Technology — HongQing Technology is a satellite networking solution provider, focusing on low-orbit broadband Internet communication satellite business, and is committed to providing large-scale satellite manufacturing and satellite networking overall solutions for major domestic and foreign constellation operators.
- Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.
Show more
Investment focus
- E-Commerce, Internet, Education
- Series A, Series B, Angel
- China, India, Taiwan
Portfolio highlights
- AlpsenTek — AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms.
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Reistone Biopharma — Reistone Biopharma is a clinical stage biopharmaceutical company. It is focused on rapidly developing innovative medicines through global collaborations within Research and Development
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
Show more
Investment focus
- Biotechnology, Health Care, Manufacturing
- Series D, Series B, Series E
- China, United States, Israel
Portfolio highlights
- Medlinker — Medical Alliance is a post of physician social service platform. Users are certified doctors working in the Medical Alliance, they can share knowledge, experience and insights with the other industry elite, to continue to provide high quality content for each other. Application provides a medical quiz, map that case, the anonymous social circlesand doctors and other functions, is committed to helping physicians groups, more convenient access to high-quality information from the industry
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
- Generon (Shanghai) Corporation — Generon (Shanghai) Corporation Ltd. is an integrated biotech company developing therapeutic biologics for patients world-wide. Their research & development center is located in Zhang Jiang High-Tech Park, Shanghai, China. their cGMP drug manufacturing facility is located in Economic-Technological Development Area, Beijing, China. Theirmission is “Innovating for Life” to develop innovative therapeutic biologics for global patients with unmet medical needs. They employ their proprietary, cutting-edge technology platforms to discover, develop and manufacture biologic therapeutics. They are focused on “best-in-class” and “first-in-class” recombinant therapeutic proteins to treat cancer, autoimmune and inflammatory diseases. They follow international quality standards for their product development and adhere to regulatory requirements of the CFDA, FDA and EMA. “Innovation and quality” are the soul of Generon in the generation of scientific data and in the processes of drug discovery, development and manufacturing.
Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Seed, Funding Round
- China, United States, Taiwan
Portfolio highlights
- VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
- Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
- Eos BioInnovation — Discover Eos Bioinnovation's commitment to advancing sustainable biotechnology through innovative research and development. Explore our mission and services.
Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.
Show more
Investment focus
- Wellness, Health Care, Consumer Research
- Series A
- Taiwan
Portfolio highlights
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
Sustainability
EdTech
Venture Capital
Clean Energy
Art
Web3
Organic Food
Wellness
Big Data
Video Games
Android
Publishing
B2B
Food and Beverage
Digital Media
Payments
Real Estate
Manufacturing
Finance
Education
Financial Services
Construction
Retail
Infrastructure
Sports
Beauty
Photography
Biotechnology
Franchise
Travel
eSports
Fitness
Recruiting
Mobile
Hospitality
Enterprise Software
Mobile Advertising
Music
Platforms
Email
Cannabis
Social Media
Social Network
Automotive
Social
Wine And Spirits
Medical
Medical Device
Legal
Crowdfunding
CleanTech
Local
Mobile Apps
Internet
Transportation
InsurTech
Enterprise
Film
LGBT
Oil and Gas
Fashion
Life Science
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Software
Restaurants
Social Impact
Celebrity
Blockchain
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Ghana
Egypt
Belarus
Hungary
Finland
France
Croatia
Gibraltar
Barbados
Georgia
Greece
Czech Republic
Sri Lanka
Faroe Islands
Costa Rica
Hong Kong
Bahrain
Belgium
Denmark
Bermuda
Estonia
Algeria
Ecuador
Bulgaria
Belize
Chile
Vietnam
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Peru
Liberia
Jersey
Lebanon
Norway
Mexico
Italy
Mali
Philippines
Israel
Kuwait
Mauritius
Malta
Morocco
Nicaragua
Togo
Rwanda
Slovenia
Poland
Uganda
San Marino
Sweden
Serbia
Sierra Leone
Thailand
Tanzania
Uzbekistan
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
Dominican Republic
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Romania
Jordan
Grenada
Argentina
Bangladesh
Europe
Kazakhstan
Qatar
Kenya
Cayman Islands
Cambodia
Japan
Cyprus
Oman
Latvia
Singapore
Spain
China
Armenia
Saudi Arabia
Oceania
Africa
LATAM
Asia
Brazil
Guatemala
Cameroon
Austria
Switzerland
Colombia
Seychelles
Marshall Islands
VC (Venture Capital) Funds in Taiwan by industry
Big Data
Financial Services
Cryptocurrency
Restaurants
Payments
Food and Beverage
Fashion
Manufacturing
Medical
Medical Device
Internet
Mobile
Travel
Software
FinTech
Biotechnology
Enterprise
Consumer
Biotech
Health Care
EdTech
Climate
SaaS
Real Estate
Hardware
Artificial intelligence
Retail
Web3
Mobile Apps
Education
Community
Transportation
Social Media
Music
Blockchain
Wellness
Media (entertainment)
Marketplace
Machine Learning
B2B
Energy
Impact
Sustainability
Proptech
Gaming
Agriculture (agtech)
Life Science